JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 654K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvarez, C.
Right arrow Articles by Sztul, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvarez, C.
Right arrow Articles by Sztul, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1999//1205 $5.00
The Journal of Cell Biology, Volume 147, Number 6, , 1999 1205-1222

Original Article

ER to Golgi Transport

: Requirement for P115 at a Pre-Golgi Vtc Stage



Cecilia Alvareza, Hideaki Fujitab, Ann Hubbardb, and Elizabeth Sztula

a Department of Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294
b Department of Cell Biology and Anatomy, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Department of Cell Biology, University of Alabama at Birmingham, McCallum Building, Birmingham, AL 35294.(205) 975-9131(205) 934-1465

esztul{at}uab.edu

The membrane transport factor p115 functions in the secretory pathway of mammalian cells. Using biochemical and morphological approaches, we show that p115 participates in the assembly and maintenance of normal Golgi structure and is required for ER to Golgi traffic at a pre-Golgi stage. Injection of antibodies against p115 into intact WIF-B cells caused Golgi disruption and inhibited Golgi complex reassembly after BFA treatment and wash-out. Addition of anti–p115 antibodies or depletion of p115 from a VSVtsO45 based semi-intact cell transport assay inhibited transport. The inhibition occurred after VSV glycoprotein (VSV-G) exit from the ER but before its delivery to the Golgi complex, and resulted in VSV-G protein accumulating in peripheral vesicular tubular clusters (VTCs). The p115-requiring step of transport followed the rab1-requiring step and preceded the Ca2+-requiring step. Unexpectedly, mannosidase I redistributed from the Golgi complex to colocalize with VSV-G protein arrested in pre-Golgi VTCs by p115 depletion. Redistribution of mannosidase I was also observed in cells incubated at 15°C. Our data show that p115 is essential for the translocation of pre-Golgi VTCs from peripheral sites to the Golgi stack. This defines a previously uncharacterized function for p115 at the VTC stage of ER to Golgi traffic.

Key Words: VTCs • Golgi complex • p115 • ER–Golgi transport

© 1999 The Rockefeller University Press

Abbreviations used in this paper: BFA, brefeldin A; COP, coat protein; endo-D, endoglycosidase D; endo-H, endoglycosidase H; ERGIC, ER–Golgi intermediate compartment; Mann I/II, mannosidase I and II, respectively; NAGT-1, N-acetylglucosamine transferase I; NRK, normal rat kidney; SNAP, soluble NSF attachment protein; v- and t-SNARES, vesicle- and target-SNAP receptors; VSV, vesicular stomatitis virus; VSV-G, VSV glycoprotein; VSVtsO45, temperature-sensitive strain of VSV; VTCs, vesicular tubular clusters.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents